#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Systemic lupus erythematosus

Recruiting

Registered drugNo placebo

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Recruiting

Registered drugNo placebo

Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dimeticone

Contact Research Centre

Sickle cell disease

Recruiting

Registered drug

Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Adenocarcinoma pancreas+1

Recruiting

Registered drugNo placebo

Evaluating 68Ga-FAPI-46 PET/CT Scanning for Improved Diagnosis in Patients with Pancreatic Cancer or Bile Duct Cancer Eligible for Curative Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Urethral valves

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Circumcision and Antibiotic Treatment (Cefaclor, Sulfamethoxazole, Trimethoprim) for Boys with Posterior Urethral Valves

Registered drugNo placebo

France

Participants:0–17 years
Substances:Amoxicillin

Contact Research Centre

Premature ejaculation

Recruiting

Investigational

Study on the Effectiveness of BP1.4979 for Adult Men with Premature Ejaculation

Investigational

France

Participants:18–64 years
Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study on Stopping Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia Who Are Responding to Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Peritonitis+1

Recruiting

Registered drug

Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Caspofungin

Contact Research Centre

Colon cancer

Recruiting

Registered drugNo placebo

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Subarachnoid haemorrhage

Recruiting

Registered drug

Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Atrial fibrillation+1

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Apixaban and Warfarin for Patients with End-Stage Renal Disease on Peritoneal Dialysis and Atrial Fibrillation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.